advisorsecurities master

TCRTAlaunos Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
22363
Ticker
TCRT
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2005-08-24
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
TCRT

Detail

Enriched 2026-08-14 20:47

Market cap
$4,884,292
Shares outstanding (class)
24,422,146
Shares outstanding (weighted)
2,442,146
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
1
Location
FORT LAUDERDALE, FL
Description

Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data